These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10369989)

  • 1. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
    Ongolo-Zogo P; Thiesse P; Sau J; Desuzinges C; Blay JY; Bonmartin A; Bochu M; Philip T
    Eur Radiol; 1999; 9(5):907-14. PubMed ID: 10369989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
    Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
    Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
    Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S
    Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
    Hanna SL; Parham DM; Fairclough DL; Meyer WH; Le AH; Fletcher BD
    Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
    van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
    AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma.
    Edeline V; Frouin F; Bazin JP; Di Paola M; Kalifa C; Contesso G; Parmentier C; Lumbroso J; Di Paola R
    Eur J Nucl Med; 1993 Dec; 20(12):1175-85. PubMed ID: 8299653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
    Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
    Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
    Shapeero LG; Henry-Amar M; Vanel D
    Invest Radiol; 1992 Nov; 27(11):989-91. PubMed ID: 1464523
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
    Fletcher BD; Hanna SL; Fairclough DL; Gronemeyer SA
    Radiology; 1992 Jul; 184(1):243-8. PubMed ID: 1319075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
    Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
    Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy.
    Reddick WE; Bhargava R; Taylor JS; Meyer WH; Fletcher BD
    J Magn Reson Imaging; 1995; 5(6):689-94. PubMed ID: 8748487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results.
    Hanna SL; Reddick WE; Parham DM; Gronemeyer SA; Taylor JS; Fletcher BD
    J Magn Reson Imaging; 1993; 3(6):849-53. PubMed ID: 8280973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
    Bielack S; Knop J; Delling G; Winkler K
    Nuklearmedizin; 1988 Dec; 27(6):237-41. PubMed ID: 2464164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
    Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
    Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.
    Miwa S; Shirai T; Taki J; Sumiya H; Nishida H; Hayashi K; Takeuchi A; Ooi A; Tsuchiya H
    Int J Clin Oncol; 2011 Aug; 16(4):373-8. PubMed ID: 21331769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
    Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
    Erlemann R; Sciuk J; Bosse A; Ritter J; Kusnierz-Glaz CR; Peters PE; Wuisman P
    Radiology; 1990 Jun; 175(3):791-6. PubMed ID: 2188300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total body bone scan in the evaluation of tumor response to preoperative chemotherapy in the treatment of osteosarcoma.
    Manfrini M; Rimondi E; Bruno A; Capanna R; Albisinni U; Picci P; Bacci G; Gaiani L; Tarozzi C
    Chir Organi Mov; 1990; 75(4):325-30. PubMed ID: 2098218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
    Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
    J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.